Skip to main content
Skip to main content
FITX logo

Creative Edge Nutrition, Inc. (FITX)

$0.00 +$0.00 (+0.00%) |CouncilHOLD · 49 · C
Bottom line: HOLD — our Council read (49/100) and AI Score (49/100) broadly agree.
MCap: 47K| Vol: 223.1K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Creative Edge Nutrition, Inc. (FITX) trades at $0.00 with AI Score 49/100 (Grade C). Creative Edge Nutrition, Inc. develops and sells health-oriented nutrition products across categories like weight loss, metabolic enhancement, and muscle stimulation. Market cap: $47,480, Sector: Healthcare.

Price live · AI analysis from Jun 15, 2026
Creative Edge Nutrition, Inc. develops and sells health-oriented nutrition products across categories like weight loss, metabolic enhancement, and muscle stimulation. The Michigan-based company operates in the specialty and generic drug manufacturers industry, offering a diverse portfolio including MetaBolic Xtreme and Hemp Nutra Tea additives.

Analyst Coverage for FITX: FITX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates FITX against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 49/100 · C

FITX: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Creative Edge Nutrition, Inc. (FITX) Healthcare & Pipeline Overview

CEOPaul R. Thomas
Employees3
HeadquartersMadison Heights, US
IPO Year2010

Creative Edge Nutrition, Inc. is a Michigan-based developer and seller of health-oriented nutrition products, focusing on categories like weight loss, metabolic enhancement, and recovery. Operating in the specialty and generic drug manufacturers industry, the company offers a diverse product portfolio including MetaBolic Xtreme and Hyper-Infusion, catering to various wellness and performance needs.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 15, 2026

What Is the Investment Thesis for FITX?

Creative Edge Nutrition, Inc. operates in the health-oriented nutrition market, offering a diverse product line spanning weight loss, metabolic enhancement, and muscle recovery. The company's reported gross margin of 80.3% indicates strong product-level profitability, suggesting efficient cost management in its core offerings. However, this is offset by a significant negative profit margin of -82.7% and negative free cash flow of $-0.00B, reflecting substantial operational expenses relative to revenue. The company's market capitalization is $0.00B, highlighting its micro-cap status and the inherent volatility associated with such small entities, further evidenced by a Beta of -0.53. Potential value drivers could emerge from strategic expansion within its niche markets, particularly if it can leverage its high gross margins to achieve profitability. Growth catalysts might include successful new product introductions in high-demand segments like natural supplements or functional foods, or improved market penetration for existing products such as MetaBolic Xtreme or Hemp Nutra Tea. Given its small employee base, operational efficiency and targeted marketing will be crucial. Risks include intense competition in the nutrition supplement industry, regulatory changes, and the challenge of scaling operations from its current micro-cap status to achieve sustainable positive free cash flow and profit margins.

Based on FMP financials and quantitative analysis

FITX Key Highlights

  • Gross margin of 80.3% indicates strong product-level profitability for its health-oriented nutrition products.
  • Profit margin of -82.7% reflects significant operational expenses relative to revenue, leading to net losses.
  • Negative free cash flow of $-0.00B suggests ongoing cash burn from operations, requiring external funding or improved profitability.
  • Market capitalization of 47K positions the company as a micro-cap entity, often associated with higher risk and volatility.
  • Beta of -0.53 indicates a low correlation with broader market movements, which can be characteristic of micro-cap stocks with limited trading activity.

Who Are FITX's Competitors?

FITX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ALVO Alvotech $3.51 -2.77% $1.19B 69
AERI Aerie Pharmaceuticals, Inc. $15.25 +0.00% 68
KIN Kindred Biosciences, Inc. $9.25 +0.11% 68
CNVCF BioHarvest Sciences Inc. $6.30 +0.00% $109.16M 66
ALIM Alimera Sciences, Inc. $5.54 -0.18% $301.29M 60
EGRX Eagle Pharmaceuticals, Inc. $0.67 +0.00% $8.82M 60
ADMP Adamis Pharmaceuticals Corporation $0.78 +0.85% $7.25M 61
NPNKF Nippon Shinyaku Co., Ltd. $32.75 +4.30% $2.21B 61

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are FITX's Key Strengths?

  • High gross margin of 80.3% on product sales, indicating strong unit economics.
  • Diversified product portfolio addressing multiple health categories, from weight loss to muscle enhancement.
  • Established brand names for key products within its niche markets.
  • Lean operational structure with 3 employees, potentially allowing for efficiency and flexibility.

What Are FITX's Weaknesses?

  • Significant negative profit margin of -82.7%, indicating substantial operational losses.
  • Negative free cash flow of $-0.00B, suggesting ongoing cash burn.
  • Micro-cap market capitalization of 47K, implying limited scale and potential for volatility.
  • "Unknown" disclosure status on the OTC market, hindering investor transparency and due diligence.

What Could Drive FITX Stock Higher?

  • Potential launch of new products within the natural line, such as additional Hemp Nutra Tea or Nutra Coffee variations, could attract new consumer segments.
  • Strategic initiatives to improve operational efficiency and reduce the negative profit margin of -82.7%, aiming for a path towards profitability.
  • Any future public disclosures of financial results or operational updates, which could provide greater transparency to investors.
  • Efforts to expand market reach for existing products like MetaBolic Xtreme or Hyper-Infusion through targeted marketing or new distribution channels.

What Are the Key Risks for FITX?

  • Financial-distress signal — its Altman Z-Score of -8.20 sits in the distress zone (elevated bankruptcy risk).
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Persistent negative profit margin of -82.7% and negative free cash flow, indicating challenges in achieving sustainable profitability.
  • Intense competition within the health-oriented nutrition products market from larger, more established companies.
  • The "Unknown" disclosure status on the OTC market, which limits investor access to critical financial and operational information.
  • Regulatory changes or increased scrutiny in the supplement and natural products industry could impact product development and sales.
  • Challenges associated with operating as a micro-cap company with a 47K market cap, including limited access to capital and low liquidity.

What Are the Growth Opportunities for FITX?

  • Expansion in Natural and Functional Foods Market: The demand for natural and functional food additives, exemplified by products like Hemp Nutra Tea and Nutra Coffee, represents a significant growth avenue. Consumers are increasingly seeking health benefits from everyday food and beverage items, driving a market projected to reach substantial figures globally. Creative Edge Nutrition could leverage its existing natural line to introduce more innovative, health-conscious additives or ready-to-consume products, expanding its footprint beyond traditional supplements and tapping into a broader consumer base looking for holistic wellness solutions. This strategy could unfold over the next 3-5 years, capitalizing on the clean label and plant-based trends.
  • Increased Penetration in Sports Nutrition: The sports nutrition market, encompassing pre-workout, intra-workout, and post-workout supplements like Hyper-Infusion and Amino Plex, continues to grow as fitness culture expands globally. Creative Edge Nutrition has an opportunity to deepen its market penetration by enhancing its product formulations, securing endorsements, or expanding distribution channels within gyms, specialized retailers, and e-commerce platforms. Focusing on the efficacy and scientific backing of its muscle enhancement and recovery products could attract a larger share of athletes and active individuals. This growth driver is ongoing, with potential for significant gains within the next 2-4 years as the fitness industry evolves.
  • Targeted Weight Management Solutions: With products like MetaBolic Xtreme, Creative Edge Nutrition is positioned within the robust weight loss market. This segment is perpetually driven by consumer desire for effective and safe solutions. A growth opportunity lies in refining and expanding its weight loss offerings, potentially incorporating personalized nutrition approaches or developing synergistic product bundles. Emphasizing clinical research or user testimonials, where applicable, could build credibility and market share. The global weight management market is a multi-billion dollar industry, offering sustained demand for innovative products over the long term, particularly over the next 5-7 years as health concerns related to obesity persist.
  • E-commerce and Direct-to-Consumer (DTC) Channel Optimization: Given its small operational footprint, optimizing e-commerce and direct-to-consumer sales channels presents a cost-effective growth opportunity. By investing in digital marketing, user experience on its website, and efficient logistics, Creative Edge Nutrition can reach a wider audience without the overhead of extensive physical retail presence. A strong DTC strategy allows for direct customer feedback, faster product iteration, and higher margin retention. This digital-first approach is an ongoing opportunity, with continuous improvements yielding benefits over the next 1-3 years in terms of customer acquisition and brand loyalty.
  • Strategic Partnerships and Co-branding: Collaborating with fitness influencers, health and wellness coaches, or complementary brands could significantly amplify Creative Edge Nutrition's market reach and credibility. Strategic partnerships could involve co-developing products, cross-promotional campaigns, or leveraging established distribution networks. For instance, partnering with a popular fitness app could introduce products like Hyper-Infusion to a highly engaged user base. Such alliances could provide access to new customer segments and enhance brand visibility, offering a scalable growth pathway over the next 3-5 years without requiring substantial internal capital investment.

What Opportunities Does FITX Have?

  • Growing demand for natural and functional food products, aligning with its Hemp Nutra Tea and Nutra Coffee additives.
  • Potential for increased penetration and expansion within the global sports nutrition market.
  • Optimization of e-commerce and direct-to-consumer sales channels to reach a wider audience efficiently.
  • Strategic partnerships with influencers or complementary brands to amplify market reach and credibility.

What Threats Does FITX Face?

  • Intense competition from larger, well-funded players in the highly saturated nutrition supplement industry.
  • Potential for adverse regulatory changes or increased scrutiny in the health and wellness product market.
  • Challenges in scaling operations and achieving sustainable profitability from its current micro-cap status.
  • Reliance on a small employee base, which could pose operational risks in terms of capacity and expertise.

What Are FITX's Competitive Advantages?

  • Proprietary product formulations across its diverse range of health and nutrition categories.
  • Established brand names for key products such as MetaBolic Xtreme, Hyper-Infusion, and Alpha-Drive.
  • Niche market focus within the broader health and wellness industry, targeting specific consumer needs.
  • Agile operational structure with a small employee base, potentially allowing for quick adaptation to market trends and product development.

What Does FITX Do?

Creative Edge Nutrition, Inc., headquartered in Madison Heights, Michigan, operates within the healthcare sector, specifically as a developer and seller of health-oriented nutrition products. The company, which was formerly known as Laufer Bridge Enterprises Inc. before changing its name to Creative Edge Nutrition, Inc. in April 2012, has established a portfolio designed to address various aspects of health and wellness. Its product offerings span several key categories, including weight loss, metabolic enhancement, recovery/well-being, muscle enhancement and stimulation, and a natural line. This diversified approach allows Creative Edge Nutrition to target a broad consumer base seeking nutritional support for different health objectives, from athletic performance to general wellness. Among its notable products, MetaBolic Xtreme is positioned for weight loss, aiming to support individuals in their body composition goals. Hyper-Infusion serves as a pre-workout powder, specifically formulated to enhance endurance and strength for athletes and fitness enthusiasts seeking to maximize their training output. For post-workout recovery and hormonal support, the company offers Alpha-Drive, a product designed for post cycle therapy, which caters to a niche segment within the muscle enhancement market. Amino Plex functions as an intra-workout recovery catalyst, emphasizing the importance of sustained performance and muscle repair during exercise, thereby supporting continuous physical activity. Beyond performance-focused supplements, Creative Edge Nutrition also addresses general health and well-being with products like Chia Plex, which leverages the nutritional benefits of chia seeds. Furthermore, the company has ventured into the natural beverage additive market with Hemp Nutra Tea and Nutra Coffee additives, indicating a strategic move towards incorporating natural ingredients into daily consumption habits and expanding its reach within the broader health food segment. With a lean operational structure supported by three employees, Creative Edge Nutrition, Inc. focuses on developing and marketing these specialized nutritional supplements to consumers across its established product categories.

What Products and Services Does FITX Offer?

  • Develops and sells a portfolio of health-oriented nutrition products.
  • Offers products for weight loss, including MetaBolic Xtreme.
  • Provides supplements for metabolic enhancement.
  • Markets recovery and well-being products, such as Chia Plex.
  • Sells muscle enhancement and stimulation products like Hyper-Infusion and Alpha-Drive.
  • Features a natural product line, including Hemp Nutra Tea and Nutra Coffee additives.
  • Operates within the specialty and generic drug manufacturers industry.
  • Based in Madison Heights, Michigan, with a small team of 3 employees.

How Does FITX Make Money?

  • Generates revenue through the direct sale of its proprietary health-oriented nutrition supplements.
  • Develops and formulates products across various health categories to address specific consumer needs.
  • Likely utilizes e-commerce platforms and potentially wholesale distribution channels for product sales.
  • Relies on product innovation and targeted marketing to drive consumer purchases and brand recognition.

What Industry Does FITX Operate In?

Creative Edge Nutrition, Inc. operates within the highly competitive and dynamic Drug Manufacturers - Specialty & Generic industry, specifically focusing on the health-oriented nutrition products segment. This market is characterized by evolving consumer preferences towards wellness, natural ingredients, and performance-enhancing supplements. The company's product categories, including weight loss, metabolic enhancement, and muscle recovery, align with significant market trends driven by increasing health consciousness and an aging global population seeking to maintain vitality. However, the industry also faces intense competition from established pharmaceutical companies, large consumer goods corporations, and numerous smaller, agile supplement brands. Creative Edge Nutrition, with its lean structure and specialized product lines like MetaBolic Xtreme and Hemp Nutra Tea, positions itself as a niche player aiming to capture specific segments of this broad market. Its ability to differentiate products and effectively market to its target demographic will be critical for navigating this crowded landscape.

Who Are FITX's Key Customers?

  • Individuals seeking effective weight loss solutions and metabolic support.
  • Athletes and fitness enthusiasts focused on enhancing performance, endurance, muscle growth, and recovery.
  • Consumers interested in general health and well-being through natural supplements.
  • Individuals looking for natural additives to incorporate into their daily beverages.
  • Niche segments within the sports nutrition and wellness markets.
AI Confidence: 65% Updated: Jun 15, 2026

Key Financial Metrics

Return on assets is -69.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 15.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.34 means current liabilities exceed short-term assets, a liquidity point worth watching.

How Creative Edge Nutrition, Inc. Is Valued

Creative Edge Nutrition, Inc. carries a market capitalization of 47K, placing it in the micro-cap category. Relative to its peer group, FITX's quantitative score of 49/100 is below the peer average of 66/100.

F-Score 2/9Financial Health

Creative Edge Nutrition, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -8.20 places it in the distress zone, a signal of elevated financial risk.

FITX Financials

Fundamental Snapshot

Return on Equity (TTM)
-218.4%
Current Ratio
0.3

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in the company's future, indicating that those closest to the business believe in its potential.
  • Community sentiment has shown a noticeable increase in optimism, with discussions highlighting innovative product launches that may attract consumer interest.
  • The company's focus on health and wellness aligns with current market trends, appealing to a growing demographic seeking nutritional supplements.
  • Recent partnerships with fitness influencers have boosted brand visibility, creating a positive buzz around the company's offerings.

Bear Case

  • Concerns over regulatory challenges in the nutritional supplement industry have emerged, creating uncertainty around future operations.
  • Some community members express skepticism about the company's growth strategy, questioning its ability to compete against larger, established brands.
  • Recent financial disclosures revealed slower-than-expected sales growth, leading to doubts about the company's short-term performance.
  • Market perception remains cautious as investors weigh the potential risks against the backdrop of a highly competitive marketplace.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

FITX Latest News

FITX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FITX.

Price Targets

Wall Street price target analysis for FITX.

FITX MoonshotScore

49/100

What does this score mean?

The MoonshotScore rates FITX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Paul R. Thomas

CEO

Paul R. Thomas serves as the leader of Creative Edge Nutrition, Inc., overseeing its operations and strategic direction. While specific details regarding his prior career history, educational background, or previous executive roles are not provided in the available data, his current position involves managing a lean team of three employees. This suggests a hands-on leadership approach, crucial for a company operating with a small workforce in the specialized nutrition products sector. His role encompasses guiding the company's product development, market positioning, and overall business strategy within the competitive healthcare industry.

Track Record: Under Paul R. Thomas's leadership, Creative Edge Nutrition, Inc. has maintained a portfolio of health-oriented nutrition products across various categories including weight loss and muscle enhancement. The company continues to offer products such as MetaBolic Xtreme and Hyper-Infusion. His tenure has seen the company operate with a notable gross margin of 80.3%, indicating effective cost management at the product level. The strategic decision to diversify into natural line products like Hemp Nutra Tea also reflects an adaptation to evolving consumer trends.

FITX OTC Market Information

Creative Edge Nutrition, Inc. trades on the OTC market under the "OTC Other" tier. This tier typically includes companies that do not meet the disclosure or financial standards of higher OTC tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. Companies in the "OTC Other" category may not provide current financial information to OTC Markets Group, making it challenging for investors to access comprehensive data. Unlike companies on major exchanges that adhere to strict SEC reporting requirements, "OTC Other" companies have significantly fewer obligations, leading to reduced transparency and increased investor risk.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Given the company's 47K market capitalization and its "OTC Other" tier classification with an unknown disclosure status, liquidity for FITX stock is likely very low. Low liquidity means fewer buyers and sellers, which can lead to wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. Trading volumes are typically minimal, increasing price volatility and the potential for significant price swings on small trades.
OTC Risk Factors:
  • Limited public information due to "Unknown" disclosure status, hindering informed investment decisions.
  • Extremely low liquidity, leading to wide bid-ask spreads and difficulty in executing trades.
  • Higher susceptibility to fraud and manipulation due to less regulatory oversight compared to major exchanges.
  • Potential for significant price volatility due to low trading volume and small market capitalization.
  • Difficulty in obtaining reliable valuation metrics without consistent financial reporting.
Due Diligence Checklist:
  • Verify any available financial statements directly from the company or third-party sources.
  • Research management's background and track record beyond provided data.
  • Assess the competitive landscape and market position of its products independently.
  • Investigate any news or press releases from reputable sources, if available.
  • Understand the company's operational history and any past regulatory issues.
  • Evaluate the current product portfolio and market demand for its specific offerings.
  • Consider the potential for delisting or further deterioration of trading status.
Legitimacy Signals:
  • Identified CEO, Paul R. Thomas, managing the company's operations.
  • Established headquarters in Madison Heights, Michigan, US, indicating a physical presence.
  • Specific product names and categories are detailed in its business description, suggesting tangible offerings.
  • History of name change from Laufer Bridge Enterprises Inc. in 2012, indicating some operational longevity.

What Investors Ask About Creative Edge Nutrition, Inc. (FITX) — Healthcare

What does Creative Edge Nutrition, Inc. do?

Creative Edge Nutrition, Inc. specializes in the development and sale of a diverse portfolio of health-oriented nutrition products. Based in Madison Heights, Michigan, the company offers supplements across several key categories, including weight loss (e.g., MetaBolic Xtreme), metabolic enhancement, recovery/well-being (e.g., Chia Plex), and muscle enhancement and stimulation (e.g., Hyper-Infusion, Alpha-Drive, Amino Plex). Additionally, it has a natural line featuring innovative products like Hemp Nutra Tea and Nutra Coffee additives. The company aims to cater to a broad spectrum of consumer health and wellness needs, positioning itself within the specialty and generic drug manufacturers industry by focusing on niche nutritional solutions.

What are the main risks for FITX?

Creative Edge Nutrition, Inc. faces several significant risks. Operationally, the company exhibits a substantial negative profit margin of -82.7% and negative free cash flow, indicating ongoing financial challenges in achieving sustainable profitability. The highly competitive health-oriented nutrition market poses a constant threat, with numerous larger and well-funded competitors. Furthermore, its "Unknown" disclosure status on the OTC market severely limits the availability of crucial financial and operational information for investors, increasing investment risk. Potential regulatory changes in the supplement industry could also impact product development and market access. Lastly, its micro-cap status with a 47K market capitalization implies inherent volatility, low liquidity, and limited access to capital.

How does Creative Edge Nutrition, Inc. position itself within the specialty nutrition market?

Creative Edge Nutrition, Inc. positions itself within the specialty nutrition market by offering a targeted range of health-oriented products across distinct categories, rather than broad, general wellness items. Its strategy involves developing specialized solutions for specific consumer needs, such as MetaBolic Xtreme for weight loss, Hyper-Infusion for pre-workout performance, and Alpha-Drive for post-cycle therapy. This niche focus allows the company to cater to particular segments of the health and fitness demographic. By also incorporating natural line products like Hemp Nutra Tea, it demonstrates an adaptability to evolving consumer preferences for natural and functional ingredients, aiming to carve out market share through product differentiation and addressing specific physiological requirements within the broader healthcare sector.

Given its OTC status, what are the implications for investors in Creative Edge Nutrition, Inc.?

Investing in Creative Edge Nutrition, Inc. as an OTC "OTC Other" tier stock carries several implications. The "Unknown" disclosure status means investors have very limited access to current and comprehensive financial reports, making it difficult to perform thorough due diligence or accurately assess the company's valuation and performance. This lack of transparency increases investment risk significantly. Furthermore, OTC "Other" stocks typically suffer from extremely low liquidity, leading to wide bid-ask spreads and challenges in buying or selling shares efficiently. The small market capitalization of 47K also contributes to high price volatility. Investors should be aware of the reduced regulatory oversight compared to major exchanges, which can expose them to greater risks of market manipulation and fraud.

What are the key factors to evaluate for FITX?

Creative Edge Nutrition, Inc. (FITX) holds an AI score of 49/100 (low). Not financial advice.

How frequently does FITX data refresh on this page?

FITX prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven FITX's recent stock price performance?

Creative Edge Nutrition, Inc. (FITX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: High gross margin of 80.3% on product sales, indicating strong unit economics. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider FITX overvalued or undervalued right now?

Valuing Creative Edge Nutrition, Inc. (FITX) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Data Sources

Popular Stocks